e-Therapeutics (ETX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 30.80p
   
  • Change Today:
      0.000p
  • 52 Week High: 32.55
  • 52 Week Low: 12.55
  • Currency: UK Pounds
  • Shares Issued: 514.55m
  • Volume: 16,899
  • Market Cap: 158.48m

e-Therapeutics Overview

e-Therapeutics is in the pharma and biotech sector and is currently trading at 30.80p per share. In the last year e-Therapeutics's share price has ranged from 12.55p to 32.55p.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -1403.1% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 495.3 n/a
Pr/Book 11.4  
Latest F'cast
Revenue -30.4% -100.0%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

e-Therapeutics Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Jan-17 n/a (16.20) (4.91)p n/a n/a n/a n/a 0.0%
31-Jan-18 n/a (6.72) (2.00)p n/a n/a n/a n/a 0.0%
31-Jan-19 0.04 (5.09) (1.49)p n/a n/a n/a n/a 0.0%
31-Jan-20 0.46 (2.87) (0.87)p n/a n/a n/a n/a 0.0%
31-Jan-21 0.32 (4.47) (0.99)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

e-Therapeutics Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Jan-22 n/a n/a n/a n/a n/a n/a n/a 0.0%
31-Jan-23 n/a n/a n/a n/a n/a n/a n/a 0.0%

Copyright © 2021 FactSet Research Systems Inc. All rights reserved.

e-Therapeutics Company Announcements

Second Price Monitoring Extn 02-Sep-2021 16:41 RNS
Price Monitoring Extension 02-Sep-2021 16:35 RNS
Director Dealing and Issue of Equity 06-Jul-2021 07:00 RNS

Latest e-Therapeutics Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

e-Therapeutics Market Data

Currency UK Pounds
Share Price 30.80p
Change Today 0.000p
% Change 0.00 %
52 Week High 32.55
52 Week Low 12.55
Volume 16,899
Shares Issued 514.55m
Market Cap 158.48m

e-Therapeutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
56.42% below the market average56.42% below the market average56.42% below the market average56.42% below the market average56.42% below the market average
Sector averageSector averageSector averageSector averageSector average
Price Trend
91.91% above the market average91.91% above the market average91.91% above the market average91.91% above the market average91.91% above the market average
83.87% above the sector average83.87% above the sector average83.87% above the sector average83.87% above the sector average83.87% above the sector average
Income Not Available
Growth
9.93% above the market average9.93% above the market average9.93% above the market average9.93% above the market average9.93% above the market average
Sector averageSector averageSector averageSector averageSector average

e-Therapeutics Dividends

No dividends found

Trades for 20-Sep-2021

Time Volume / Share Price
11:24 3,173 @ 29.59p
09:36 6,726 @ 29.64p
09:20 2,000 @ 29.01p
09:01 5,000 @ 29.01p

e-Therapeutics Key Personnel

Chair Trevor Mervyn Jones
CEO Ali Mortazavi

Top of Page